Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Combination peptide immunotherapy suppresses antibody and helper T-cell responses to the major human platelet autoantigen glycoprotein IIb/IIIa in HLA-transgenic mice.

Hall LS, Lennon CS, Hall AM, Urbaniak SJ, Vickers MA, Barker RN.

Haematologica. 2019 May;104(5):1074-1082. doi: 10.3324/haematol.2017.179424. Epub 2018 Dec 4.

2.

Combination peptide immunotherapy suppresses antibody and helper T-cell responses to the RhD protein in HLA-transgenic mice.

Hall LS, Hall AM, Pickford W, Vickers MA, Urbaniak SJ, Barker RN.

Haematologica. 2014 Mar;99(3):588-96. doi: 10.3324/haematol.2012.082081. Epub 2014 Jan 17.

3.

Identification, immunomodulatory activity, and immunogenicity of the major helper T-cell epitope on the K blood group antigen.

Stephen J, Cairns LS, Pickford WJ, Vickers MA, Urbaniak SJ, Barker RN.

Blood. 2012 Jun 7;119(23):5563-74. doi: 10.1182/blood-2012-02-410324. Epub 2012 Apr 5.

4.

Routine antenatal anti-D prophylaxis in women who are Rh(D) negative: meta-analyses adjusted for differences in study design and quality.

Turner RM, Lloyd-Jones M, Anumba DO, Smith GC, Spiegelhalter DJ, Squires H, Stevens JW, Sweeting MJ, Urbaniak SJ, Webster R, Thompson SG.

PLoS One. 2012;7(2):e30711. doi: 10.1371/journal.pone.0030711. Epub 2012 Feb 3.

5.

The cellular immunobiology associated with fetal and neonatal alloimmune thrombocytopenia.

Stuge TB, Skogen B, Ahlen MT, Husebekk A, Urbaniak SJ, Bessos H.

Transfus Apher Sci. 2011 Aug;45(1):53-9. doi: 10.1016/j.transci.2011.06.003. Epub 2011 Jun 25. Review.

PMID:
21708486
6.

Naturally processed peptides spanning the HPA-1a polymorphism are efficiently generated and displayed from platelet glycoprotein by HLA-DRB3*0101-positive antigen-presenting cells.

Anani Sarab G, Moss M, Barker RN, Urbaniak SJ.

Blood. 2009 Aug 27;114(9):1954-7. doi: 10.1182/blood-2009-04-211839. Epub 2009 Jun 3.

7.

The relationship of anti-HPA-1a amount to severity of neonatal alloimmune thrombocytopenia - Where does it stand?

Bessos H, Killie MK, Seghatchian J, Skogen B, Urbaniak SJ.

Transfus Apher Sci. 2009 Apr;40(2):75-8. doi: 10.1016/j.transci.2009.01.010. Epub 2009 Feb 14.

PMID:
19223235
8.

Direct comparison between two quantitative assays in the measurement of maternal anti-HPA-1a antibody in neonatal alloimmune thrombocytopenia (NAIT).

Bessos H, Killie MK, Matviyenko M, Husebekk A, Urbaniak SJ.

Transfus Apher Sci. 2008 Dec;39(3):221-7. doi: 10.1016/j.transci.2008.09.006. Epub 2008 Oct 21.

PMID:
18945639
9.

What's happening--probing of HPA-1a antigen-antibody interaction by surface plasmon resonance technology.

Bessos H, Matviyenko M, Brown P, Husebekk A, Killie MK, Seghatchian J, Santoso S, Urbaniak SJ.

Transfus Apher Sci. 2008 Oct;39(2):179-82. doi: 10.1016/j.transci.2008.06.005.

PMID:
18710823
10.

Noninvasive approaches to the management of RhD hemolytic disease of the fetus and newborn.

Urbaniak SJ.

Transfusion. 2008 Jan;48(1):2-5. doi: 10.1111/j.1537-2995.2007.01557.x. No abstract available.

PMID:
18184231
11.

Management of alloimmune thrombocytopenia.

Kanhai HH, Porcelijn L, Engelfriet CP, Reesink HW, Panzer S, Ulm B, Goldman M, Bonacossa I, Richard L, David M, Taaning E, Hedegaard M, Kaplan C, Kiefel V, Meyer O, Salama A, Morelati F, Greppi N, Marconi M, Tassis B, Tsuno NH, Takahashi K, Oepkes D, Porcelijn L, Kanhai H, Osnes LT, Husebekk A, Killie MK, Kjeldsen-Kragh J, Zupanska B, Muñiz-Diaz E, Nogués N, Parra J, Urbaniak SJ, Cameron A.

Vox Sang. 2007 Nov;93(4):370-85. No abstract available.

PMID:
18070283
12.

Deletion of the dominant autoantigen in NZB mice with autoimmune hemolytic anemia: effects on autoantibody and T-helper responses.

Hall AM, Ward FJ, Shen CR, Rowe C, Bowie L, Devine A, Urbaniak SJ, Elson CJ, Barker RN.

Blood. 2007 Dec 15;110(13):4511-7. Epub 2007 Sep 4.

13.

Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia.

Ward FJ, Hall AM, Cairns LS, Leggat AS, Urbaniak SJ, Vickers MA, Barker RN.

Blood. 2008 Jan 15;111(2):680-7. Epub 2007 Aug 30.

14.

Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune thrombocytopenic purpura.

Sukati H, Watson HG, Urbaniak SJ, Barker RN.

Blood. 2007 May 15;109(10):4528-38. Epub 2007 Feb 1.

15.

Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction.

Sadani DT, Urbaniak SJ, Bruce M, Tighe JE.

Transfus Med. 2006 Oct;16(5):375-9.

PMID:
16999762
16.

The analysis and quantification of a clonal B cell response in a hyperimmunized anti-D donor.

Dohmen SE, Verhagen OJ, de Groot SM, Stott LM, Aalberse RC, Urbaniak SJ, van der Schoot CE.

Clin Exp Immunol. 2006 May;144(2):223-32.

17.

Alloimmunity to RhD in humans.

Urbaniak SJ.

Transfus Clin Biol. 2006 Mar-Apr;13(1-2):19-22. Epub 2006 Mar 30. Review.

PMID:
16574456
18.
19.

Report on the 12th International Society of Blood Transfusion platelet immunology workshop.

Bessos H, Wilson DW, Metcalfe P, Allen D, Urbaniak SJ.

Vox Sang. 2005 Aug;89(2):105-13.

PMID:
16101693
20.

Transfusion related acute lung injury (TRALI).

Urbaniak SJ.

Br J Haematol. 2005 Aug;130(3):463-4; author reply 464. No abstract available.

PMID:
16042702
22.

Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice.

Hall AM, Cairns LS, Altmann DM, Barker RN, Urbaniak SJ.

Blood. 2005 Mar 1;105(5):2175-9. Epub 2004 Sep 21.

23.

Donor exposure rate to transfusion ratio: a better discriminator of improvement in neonatal transfusion practice.

Ibojie J, Greiss M, Lloyd DJ, Urbaniak SJ.

Transfus Med. 2003 Oct;13(5):287-91.

PMID:
14617339
24.

Genetic polymorphism of HLA DR in a Scottish population of patients with pars planitis.

Greiner KH, Wilson DW, Thomson J, Kilmartin DJ, Urbaniak SJ, Forrester JV.

Eur J Ophthalmol. 2003 Jun;13(5):433-8.

PMID:
12841565
25.

Conductivity of LISS solutions.

Urbaniak SJ, Knight R.

Transfus Med. 2003 Apr;13(2):100. No abstract available.

PMID:
12694556
26.

Antenatal screening for fetomaternal alloimmune thrombocytopenia: should we be doing it?

Murphy MF, Williamson LM, Urbaniak SJ.

Vox Sang. 2002 Aug;83 Suppl 1:409-16. Review. No abstract available.

PMID:
12617177
27.

Alloimmunity to human red blood cell antigens.

Urbaniak SJ.

Vox Sang. 2002 Aug;83 Suppl 1:293-7. Review. No abstract available.

PMID:
12617156
28.

Limited efficacy of universal leucodepletion in reducing the incidence of febrile non-haemolytic reactions in red cell transfusion.

Ibojie J, Greiss M, Urbaniak SJ.

Transfus Med. 2002 Dec;12(6):387-9. No abstract available.

PMID:
12473158
29.

Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen.

Hall AM, Ward FJ, Vickers MA, Stott LM, Urbaniak SJ, Barker RN.

Blood. 2002 Dec 15;100(13):4529-36. Epub 2002 Aug 1.

30.

Semiautomated data analysis of flow cytometric estimation of fetomaternal hemorrhage in D- women.

Greiss MA, Armstrong-Isher SS, Perera WS, Brown PM, Urbaniak SJ.

Transfusion. 2002 Aug;42(8):1067-78.

PMID:
12385420
31.
32.

Fetomaternal alloimmune thrombocytopenia.

Ahya R, Turner ML, Urbaniak SJ; SNAIT Study Team.

Transfus Apher Sci. 2001 Oct;25(2):139-45. Review.

PMID:
11761276
33.

Comparison between hybridoma and Fab/phage anti-RhD: their V gene usage and pairings.

Perera WS, Moss MT, Urbaniak SJ.

Dis Markers. 2000;16(1-2):15-9. Review.

34.

In vivo platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or Ib.

Meiklejohn DJ, Vickers MA, Morrison ER, Dijkhuisen R, Moore I, Urbaniak SJ, Greaves M.

Br J Haematol. 2001 Mar;112(3):621-31.

PMID:
11260063
35.

Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients.

Kilmartin DJ, Wilson D, Liversidge J, Dick AD, Bruce J, Acheson RW, Urbaniak SJ, Forrester JV.

Br J Ophthalmol. 2001 Mar;85(3):281-6.

36.

Identification of alloreactive T-cell epitopes on the Rhesus D protein.

Stott LM, Barker RN, Urbaniak SJ.

Blood. 2000 Dec 15;96(13):4011-9.

37.

Quality of harvested autologous platelets compared with stored donor platelets for use after cardiopulmonary bypass procedures.

Crowther M, Ford I, Jeffrey RR, Urbaniak SJ, Greaves M.

Br J Haematol. 2000 Oct;111(1):175-81.

PMID:
11091198
38.
39.

RhD haemolytic disease of the fetus and the newborn.

Urbaniak SJ, Greiss MA.

Blood Rev. 2000 Mar;14(1):44-61. Review.

PMID:
10805260
40.
41.

Variable inhibition of placental IgG transfer in vitro with commercial IVgG preparations.

Urbaniak SJ, Duncan JI, Armstrong-Fisher SS, Abramovich DR, Page KR.

Br J Haematol. 1999 Dec;107(4):815-7.

PMID:
10606889
42.

Evaluation of a panel of human monoclonal antibodies to D and exploration of the synergistic effects of blending IgG1 and IgG3 antibodies on their in vitro biologic function.

Armstrong-Fisher SS, Carter MC, Downing I, Fraser RH, Inglis GE, Allan EK, Mackie A, Prowse CV, Templeton JG, Thorpe SJ, Urbaniak SJ.

Transfusion. 1999 Sep;39(9):1005-12.

PMID:
10533828
44.

Platelet glycoprotein IIIa polymorphism HPA 1b (PlA2): no association with platelet fibrinogen binding.

Meiklejohn DJ, Urbaniak SJ, Greaves M.

Br J Haematol. 1999 Jun;105(3):664-6.

PMID:
10354127
45.

Epidemiology and outcome of HIV infection in North-East Scotland (1985-1997).

Mackenzie AR, Laing RB, Urbaniak SJ, Molyneaux PJ, Douglas JG, Smith CC.

J Infect. 1999 Mar;38(2):107-10.

PMID:
10342650
46.

The scientific basis of antenatal prophylaxis.

Urbaniak SJ.

Br J Obstet Gynaecol. 1998 Nov;105 Suppl 18:11-8. Review.

PMID:
9863973
48.

Underreporting of mortality from RhD haemolytic disease in Scotland and its implications: retrospective review.

Whitfield CR, Raafat A, Urbaniak SJ.

BMJ. 1997 Dec 6;315(7121):1504-5. No abstract available.

49.

A quality assurance scheme for the Kleihauer test: the Scottish experience 1988-1996.

Raafat A, Fraser N, Main R, Urbaniak SJ.

Transfus Med. 1997 Sep;7(3):221-6.

PMID:
9316223
50.

Supplemental Content

Loading ...
Support Center